EngMab

Exited

EngMab is tracked in the Tech.eu funding database. Based in Schwyz, Switzerland; founded 2013; active in Healthtech. Acquired by Celgene in 2016. Data as of 23 Aug 2026.

Schwyz, SwitzerlandFounded 2013

Healthtech

← All companies

Total raised

€0

Funding rounds

Investors

distinct backers

Active since

—

Funding rounds

0 rounds

No funding rounds recorded.

Exit

Type

acquisition

Date

May 2016

Value

€545M

Acquiror

Celgene (United States Summit)

Similar companies

same sector or country

Philips

EngMab

Funding rounds

Exit

Related news

Similar companies